BR100 Decreased By (-0.35%)
BR30 Decreased By (-0.45%)
KSE100 Decreased By (-0.29%)
KSE30 Decreased By (-0.3%)
AGHA 6.62 Decreased By ▼ -0.05 (-0.75%)
BECO 4.35 No Change ▼ 0.00 (0%)
BML 56.22 Increased By ▲ 0.05 (0.09%)
BOP 29.99 Decreased By ▼ -0.13 (-0.43%)
CNERGY 12.78 Decreased By ▼ -0.20 (-1.54%)
CSIL 5.20 Decreased By ▼ -0.11 (-2.07%)
FCCL 51.40 Decreased By ▼ -0.25 (-0.48%)
FFL 14.50 Increased By ▲ 0.01 (0.07%)
FNEL 1.21 No Change ▼ 0.00 (0%)
KEL 6.04 Decreased By ▼ -0.02 (-0.33%)
KOSM 5.77 Decreased By ▼ -0.07 (-1.2%)
LOTCHEM 26.40 Increased By ▲ 0.23 (0.88%)
MLCF 89.89 Decreased By ▼ -1.34 (-1.47%)
NBP 163.50 Decreased By ▼ -0.69 (-0.42%)
NCPL 52.79 Decreased By ▼ -0.39 (-0.73%)
NPL 58.65 Decreased By ▼ -0.47 (-0.79%)
OGDC 313.65 Increased By ▲ 0.26 (0.08%)
PACE 9.71 Decreased By ▼ -0.06 (-0.61%)
PAEL 35.02 Decreased By ▼ -0.22 (-0.62%)
PIBTL 14.62 Decreased By ▼ -0.09 (-0.61%)
PPL 219.00 Decreased By ▼ -2.36 (-1.07%)
PRL 91.19 Decreased By ▼ -0.03 (-0.03%)
PTC 59.20 Increased By ▲ 0.01 (0.02%)
SSGC 23.16 Decreased By ▼ -0.14 (-0.6%)
TBL 8.79 Increased By ▲ 0.04 (0.46%)
TELE 7.56 Decreased By ▼ -0.05 (-0.66%)
TPL 21.90 Decreased By ▼ -0.13 (-0.59%)
TPLP 12.50 Decreased By ▼ -0.06 (-0.48%)
TREET 21.70 Decreased By ▼ -0.03 (-0.14%)
TRG 55.20 Decreased By ▼ -0.59 (-1.06%)
Topic

Moderna vaccines

Moderna testing new COVID-19 vaccine as potential booster shot

Moderna testing new COVID-19 vaccine as potential booster shot

Updated 15 Mar, 2021 09:25pm
  • The early-stage study will assess the safety and immunogenicity of mRNA-1283 at three dose levels, and will be given to healthy adults either as a single dose or in two doses 28 days apart, the company said.
  • Last week, Moderna began dosing the first participants in a study testing its COVID-19 booster vaccine candidates.
EU drugs regulator gives green light to J&J's single-shot COVID-19 vaccine

EU drugs regulator gives green light to J&J's single-shot COVID-19 vaccine

Published 11 Mar, 2021 06:48pm
  • The COVID-19 shot is the fourth to be endorsed for use in the EU after vaccines from Pfizer-BioNTech , AstraZeneca-Oxford University and Moderna, and is recommended for those over 18 years of age.
  • With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens.
Loading...